Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Functional gastroduodenal disorders
- N. Talley, V. Stanghellini, R. Heading, K. Koch, J. Malagelada, G. Tytgat
- 1 September 1999
A consensus-based approach was applied, supplemented by input from international experts who reviewed the report, and a dyspepsia subgroup classification is proposed for research purposes, based on the predominant (most bothersome) symptom.
Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues.
Eos inophilic gastroenteritis should be considered in the differential diagnosis of unexplained gastrointestinal symptoms even in the absence of peripheral eosinophilia, according to the clinicopathological spectrum.
Prevalence of Barrett's esophagus in the general population: an endoscopic study.
Alcohol and smoking were significant risk factors for the prevalence of Barrett's esophagus in an adult Swedish population and the prevalence in the general population was found to be 1.6% of the general Swedish population.
U. S. Householder survey of functional gastrointestinal disorders
Symptom reporting, except for incontinence, declines with age, and low income is associated with greater symptom reporting, and the rate of work/school absenteeism and physician visits is increased for those having a functional gastrointestinal disorder.
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.
An evidence-based appraisal of reflux disease management — the Genval Workshop Report
This report summarises conclusions from an evidence-based workshop which evaluated major clinical strategies for the management of the full spectrum of gastro-oesophageal reflux disease, with an…
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- A. Ford, W. Sandborn, K. Khan, S. Hanauer, N. Talley, P. Moayyedi
- MedicineThe American Journal of Gastroenterology
- 1 April 2011
Biological therapies were superior to placebo in inducing remission of active CD and UC, and in preventing relapse of quiescent CD.
American gastroenterological association technical review on the evaluation of dyspepsia.
This work presents a meta-analyses of clinical practice and economics at the cellular level that shows clear trends in immune checkpoint disease and disease progression over time and describes these trends as well as specific cases in the United States.